IP Library Granted Patent US 6,858,709
Granted Patent B1
US 6,858,709 · App. 09/914,324 · Granted Feb 22, 2005

Component of von Hippel-Lindau tumor suppressor complex and SCF ubiquitin ligase

Assignee: Oklahoma Medical Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,709
App. No.
09/914,324
Granted
Feb 22, 2005
Kind
B1
Abstract

Rbx1, an evolutionarily conserved Cullin-interacting RING-H2 finger protein, has been discovered. Mammalian Rbx1 has been identified as a component of the CUL2-containing VHL complex. An Rbx1 homolog from S. cerevisiae has also been identified as a subunit and activator of the Cdc53-containing SCF Cdc4 ubiquitin ligase required for ubiquitination of the cdk inhibitor Sic1 and for the G1/S cell cycle transition in yeast, providing a link between the multiprotein VHL tumor suppressor complex and cellular ubiquitination. The Rbx1 protein acts as a cellular marker useful (1) in detecting a possible predisposition to certain carcinomas, (2) as a molecular target for treating those carcinomas therapeutically. (3) as a target for inhibition by drugs that manipulate the growth of cells, and (4) as a research tool to better understand the various complex mechanisms of cell ubiquitination, binding of certain activator proteins, fibronectin deposition and other aspects of the cellular division process.

Claims (12)

1. An isolated and purified biologically active Ring box protein comprising a polypeptide having an amino acid sequence corresponding to SEQ ID NO:1.

2. A recombinant Ring box protein comprising a polypeptide having an amino acid sequence corresponding to SEQ ID NO:1.

3. The Ring box protein of claim 1 , wherein the polypeptide is human.

4. A Ring box protein according to claim 2 , wherein the polypeptide is encoded by a nucleic acid comprising the sequence of SEQ ID NO:3.

5. A Ring box protein according to claim 2 , prepared by the method of culturing an isolated cell containing an expression vector comprising a nucleic acid molecule comprising the sequence of SEQ ID NO:3 under conditions suitable for expression of the nucleic acid molecule.

6. A protein complex comprising the Ring box protein of claim 1 or claim 2 .

7. The protein complex of claim 6 , further comprising one or more proteins selected from the group consisting of a cullin protein, a substrate recognition protein, and a linker protein.

8. The protein complex of claim 7 wherein the complex is a ubiquitin ligase protein complex.

9. The protein complex of claim 8 wherein the ubiquitin ligase protein complex is selected from the group consisting of SCF and VHL.

10. The ubiquitin ligase protein complex of claim 8 wherein the cullin protein is selected from the group consisting of Cdc53, Cullin 1, Cullin 2, Cullin 3, Cullin 4A, Cullin 4B, and Cullin 5.

11. The ubiquitin ligase protein complex of claim 8 wherein the substrate recognition protein is selected from the group consisting of β-TRCP, Cdc4, Grr1, VHL and Elongin C binding proteins.

12. The ubiquitin ligase protein complex of claim 8 wherein the linker protein is selected from the group consisting of Skp 1 and Elongin C.

Assignments (6)
CONFIRMATORY LICENSE Recorded Jul 3, 2017
From: OKLAHOMA MEDICAL RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043074/0744 →
CONFIRMATORY LICENSE Recorded Jun 30, 2017
From: OKLAHOMA MEDICAL RESEARCH FOUNDATION
To: NIH-DEITR
Reel/Frame 042879/0106 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE: DECEMBER 19, 1998 PREVIOUSLY RECORDED ON REEL 012918 FRAME 0569. ASSIGNOR(S) HEREBY CONFIRMS THE EXECUTION DATE: NOVEMBER 18, 1998 AND NOVEMBER 19, 1998. Recorded Jan 17, 2008
From: CONAWAY, JOAN W.; KAMURA, TAKUMI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 020385/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2002
From: CONAWAY, JOAN W.; KAMURA, TAKUMI
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 012918/0569 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2002
From: CONAWAY, RONALD C.
To: OKLAHOMA MEDICAL RESEARCH FOUNDATION
Reel/Frame 012918/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2002
From: HOWARD HUGHES MEDICAL INSTITUTE
To: OKLAHOMA MEDICAL RESEARCH FOUNDATION
Reel/Frame 012918/0801 →
Continuity (1)
Provisional Application 6012178700 · Feb 26, 1999